- Home
- GH vs DORM Comparison
GH vs DORM Comparison
Compare GH & DORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- DORM
- Stock Information
- Founded
- GH 2011
- DORM 1978
- Country
- GH United States
- DORM United States
- Employees
- GH N/A
- DORM N/A
- Industry
- GH Medical Specialities
- DORM Auto Parts:O.E.M.
- Sector
- GH Health Care
- DORM Consumer Discretionary
- Exchange
- GH Nasdaq
- DORM Nasdaq
- Market Cap
- GH 4.9B
- DORM 3.8B
- IPO Year
- GH 2018
- DORM 1991
- Fundamental
- Price
- GH $49.54
- DORM $121.74
- Analyst Decision
- GH Strong Buy
- DORM Strong Buy
- Analyst Count
- GH 20
- DORM 1
- Target Price
- GH $54.35
- DORM $153.00
- AVG Volume (30 Days)
- GH 2.0M
- DORM 182.3K
- Earning Date
- GH 08-06-2025
- DORM 07-31-2025
- Dividend Yield
- GH N/A
- DORM N/A
- EPS Growth
- GH N/A
- DORM 40.11
- EPS
- GH N/A
- DORM 6.97
- Revenue
- GH $773,996,000.00
- DORM $2,048,188,000.00
- Revenue This Year
- GH $23.14
- DORM $6.36
- Revenue Next Year
- GH $21.42
- DORM $4.77
- P/E Ratio
- GH N/A
- DORM $17.59
- Revenue Growth
- GH 28.20
- DORM 6.03
- 52 Week Low
- GH $20.14
- DORM $89.81
- 52 Week High
- GH $53.42
- DORM $146.60
- Technical
- Relative Strength Index (RSI)
- GH 56.81
- DORM 46.11
- Support Level
- GH $48.90
- DORM $122.82
- Resistance Level
- GH $52.46
- DORM $127.61
- Average True Range (ATR)
- GH 1.97
- DORM 3.43
- MACD
- GH -0.23
- DORM -0.05
- Stochastic Oscillator
- GH 48.74
- DORM 34.30
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About DORM Dorman Products Inc.
Dorman Products Inc is a supplier of original equipment parts for automobiles. It offers automotive and heavy-duty replacement parts, automotive hardware, brake parts, and fasteners for the automotive and heavy-duty aftermarket. The products are sold under the Dorman brand and its sub-brands OE Solutions, Help!, Conduct-Tite, Super ATV, etc., through aftermarket retailers, warehouse distributors, specialty markets, and salvage yards. The company operates through three business segments, which include Light Duty, Heavy Duty, and Specialty Vehicle. A majority of its revenue is generated from the Light Duty segment, which designs and markets replacement parts and fasteners mainly for passenger cars and light trucks. Geographically, it derives key revenue from the United States.